33120sek
0,8 %
Date:2026-09-08Time:17:29:56Latest report:Q2-2026List:Large CapTicker:BIOA B
Market Cap:29 392 msekEnterprise Value:27 493 msekNet Sales:1 002 msekEarnings:105,5 msekEmployees:0ISIN:SE0010323311

Ratios

10-year key figure history for BioArctic turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for BioArctic with index and moving average MA50 and MA200.

Stockprice:331,20
MA50:321,39
MA200:317,83
Price/MA200:4,2 %
RSI (14):53,1
Price/MA50:3,1 %

Description

BioArctic is a biopharmaceutical company focused on developing new treatments that address the causes of neurodegenerative diseases. Examples of diseases include Alzheimer's and Parkinson's. A large part of the research is carried out in collaboration with researchers at universities and hospitals. BioArctic was founded in 2003 and is headquartered in Stockholm.

Biotechnology